Long non-coding RNA PVT1 indicates a poor prognosis of glioma and promotes cell proliferation and invasion via target EZH2
Open Access
- 15 December 2017
- journal article
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 37 (6)
- https://doi.org/10.1042/bsr20170871
Abstract
Human glioma is one of the malignant tumors of the central nervous system (CNS). Its prognosis is poor, which is due to its genetic heterogeneity and our poor understanding of its underlying molecular mechanisms. The present study aimed to assess the relationship between plasmacytoma variant translocation 1 (PVT1) and enhancer of zeste homolog 2 (EZH2), and their effects on the proliferation and invasion of glioma cells. The expression levels of PVT1 and EZH2 in human glioma tissues and cell lines were measured using quantitative RT-PCR (qRT-PCR). Then, after siRNA-PVT1 and entire PVT1 sequence vector transfection, we determined the regulation roles of PVT1 in the proliferation, apoptosis, migration, and invasion of glioma cells. We found that the expression levels of both PVT1 and EZH2 were up-regulated in human glioma tissues and cell lines, and positively correlated with glioma malignancy. And, silencing of PVT1 expression resulted in decreased proliferation, increased apoptosis, and decreased migration and invasion. In addition, exogenous PVT1 led to increased EZH2 expression and increased proliferation and induced proliferation and invasion. These data inferred that long non-coding RNA PVT1 could be served as an indicator of glioma prognosis, and PVT1–EZH2 regulatory pathway may be a novel therapeutic target for treating glioma.This publication has 24 references indexed in Scilit:
- LncRNA PVT1 epigenetically silences miR-195 and modulates EMT and chemoresistance in cervical cancer cellsJournal of Drug Targeting, 2017
- PVT1 affects growth of glioma microvascular endothelial cells by negatively regulating miR-186Tumor Biology, 2017
- The lncRNA PVT1 Contributes to the Cervical Cancer Phenotype and Associates with Poor Patient PrognosisPLOS ONE, 2016
- Small-molecule inhibitors of FGFR, integrins and FAK selectively decrease L1CAM-stimulated glioblastoma cell motility and proliferationCellular Oncology, 2016
- Long noncoding RNA PVT1 modulates thyroid cancer cell proliferation by recruiting EZH2 and regulating thyroid-stimulating hormone receptor (TSHR)Tumor Biology, 2015
- Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16Molecular Cancer, 2015
- The hallmarks of cancerRNA Biology, 2012
- Noncoding RNA in developmentMammalian Genome, 2008
- Malignant astrocytic glioma: genetics, biology, and paths to treatmentGenes & Development, 2007
- Molecular Mechanisms of Glioma Cell Migration and InvasionJournal of Neuro-Oncology, 2004